• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PC12嗜铬细胞瘤细胞中的I1-咪唑啉受体可激活蛋白激酶C、细胞外信号调节激酶(ERK)和c-jun氨基末端激酶(JNK)。

The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK).

作者信息

Edwards L, Fishman D, Horowitz P, Bourbon N, Kester M, Ernsberger P

机构信息

Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4906, USA.

出版信息

J Neurochem. 2001 Dec;79(5):931-40. doi: 10.1046/j.1471-4159.2001.00632.x.

DOI:10.1046/j.1471-4159.2001.00632.x
PMID:11739604
Abstract

We sought to further elucidate signal transduction pathways for the I1-imidazoline receptor in PC12 cells by testing involvement of protein kinase C (PKC) isoforms (betaII, epsilon, zeta), and the mitogen-activated protein kinases (MAPK) ERK and JNK. Stimulation of I1-imidazoline receptor with moxonidine increased enzymatic activity of the classical betaII isoform in membranes by about 75% and redistributed the atypical isoform into membranes (40% increase in membrane-bound activity), but the novel isoform of PKC was unaffected. Moxonidine and clonidine also increased by greater than two-fold the proportion of ERK-1 and ERK-2 in the phosphorylated active form. In addition, JNK enzymatic activity was increased by exposure to moxonidine. Activation of ERK and JNK followed similar time courses with peaks at 90 min. The action of moxonidine on ERK activation was blocked by the I1-receptor antagonist efaroxan and by D609, an inhibitor of phosphatidylcholine-selective phospholipase C (PC-PLC), previously implicated as the initial event in I1-receptor signaling. Inhibition or depletion of PKC blocked activation of ERK by moxonidine. Two-day treatment of PC12 cells with the I1/alpha2-agonist clonidine increased cell number by up to 50% in a dose related manner. These data suggest that ERK and JNK, along with PKC, are signaling components of the I1-receptor pathway, and that this receptor may play a role in cell growth.

摘要

我们试图通过检测蛋白激酶C(PKC)亚型(βII、ε、ζ)以及丝裂原活化蛋白激酶(MAPK)ERK和JNK的参与情况,进一步阐明PC12细胞中I1-咪唑啉受体的信号转导途径。用莫索尼定刺激I1-咪唑啉受体可使膜中经典βII亚型的酶活性增加约75%,并使非典型亚型重新分布到膜中(膜结合活性增加40%),但PKC的新型亚型未受影响。莫索尼定和可乐定还使磷酸化活性形式的ERK-1和ERK-2的比例增加了两倍以上。此外,暴露于莫索尼定可增加JNK的酶活性。ERK和JNK的激活遵循相似的时间进程,在90分钟时达到峰值。莫索尼定对ERK激活的作用被I1受体拮抗剂依酚氯铵和D609(一种磷脂酰胆碱选择性磷脂酶C(PC-PLC)抑制剂,先前被认为是I1受体信号传导的初始事件)阻断。PKC的抑制或耗竭可阻断莫索尼定对ERK的激活。用I1/α2激动剂可乐定对PC12细胞进行为期两天的处理,可使细胞数量以剂量相关的方式增加多达50%。这些数据表明,ERK和JNK以及PKC是I1受体途径的信号传导成分,并且该受体可能在细胞生长中起作用。

相似文献

1
The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK).PC12嗜铬细胞瘤细胞中的I1-咪唑啉受体可激活蛋白激酶C、细胞外信号调节激酶(ERK)和c-jun氨基末端激酶(JNK)。
J Neurochem. 2001 Dec;79(5):931-40. doi: 10.1046/j.1471-4159.2001.00632.x.
2
The I(1)-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase.PC12嗜铬细胞瘤细胞中的I(1)-咪唑啉受体可逆转神经生长因子诱导的细胞外信号调节激酶激活并诱导双特异性磷酸酶2。
Brain Res. 2003 Aug 1;980(1):71-9. doi: 10.1016/s0006-8993(03)02893-2.
3
Imidazoline I(1) receptor-induced activation of phosphatidylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells.咪唑啉I(1)受体诱导的磷脂酰胆碱特异性磷脂酶C激活引发PC12细胞中的丝裂原活化蛋白激酶磷酸化。
Eur J Pharmacol. 2001 Mar;415(2-3):117-25. doi: 10.1016/s0014-2999(01)00834-2.
4
Arachidonic acid release from PC12 pheochromocytoma cells is regulated by I1-imidazoline receptors.花生四烯酸从PC12嗜铬细胞瘤细胞中的释放受I1-咪唑啉受体调控。
J Auton Nerv Syst. 1998 Oct 15;72(2-3):147-54. doi: 10.1016/s0165-1838(98)00099-x.
5
The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.I1-咪唑啉受体:从结合位点到心血管疾病治疗靶点
J Hypertens Suppl. 1997 Jan;15(1):S9-23. doi: 10.1097/00004872-199715011-00002.
6
Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
Mol Pharmacol. 1996 Apr;49(4):668-75.
7
Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein.磷脂酰胆碱选择性磷脂酶C参与咪唑啉受体抗血清选择蛋白中丝裂原活化蛋白激酶途径的激活。
J Cell Biochem. 2006 Aug 15;98(6):1615-28. doi: 10.1002/jcb.20806.
8
Activation of phosphatidylcholine-selective phospholipase C by I1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla.I1-咪唑啉受体对PC12细胞和延髓头端腹外侧区中磷脂酰胆碱选择性磷脂酶C的激活作用。
Brain Res. 1997 Feb 28;749(2):335-9. doi: 10.1016/S0006-8993(96)01372-8.
9
Cooperation between PKC-alpha and PKC-epsilon in the regulation of JNK activation in human lung cancer cells.蛋白激酶C-α(PKC-α)与蛋白激酶C-ε(PKC-ε)在人肺癌细胞中JNK激活调控中的合作。
Cell Signal. 2004 Apr;16(4):457-67. doi: 10.1016/j.cellsig.2003.09.002.
10
Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.细胞外信号调节激酶、Jun氨基末端激酶、p38和c-Src参与促性腺激素释放激素刺激的糖蛋白激素促卵泡激素β亚基启动子的活性。
Endocrinology. 2004 May;145(5):2228-44. doi: 10.1210/en.2003-1418. Epub 2004 Jan 21.

引用本文的文献

1
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.I1 咪唑啉受体:TVP1022,即雷沙吉兰 S-对映异构体的新型潜在细胞保护靶标。
PLoS One. 2012;7(11):e47890. doi: 10.1371/journal.pone.0047890. Epub 2012 Nov 15.
2
α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.α-和β-肾上腺素受体在调节成年大鼠自发和安非他命诱导的 50-kHz 超声波发声方面存在差异。
Neuropsychopharmacology. 2012 Feb;37(3):808-21. doi: 10.1038/npp.2011.258. Epub 2011 Oct 26.
3
Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor.
利美尼定通过 p38 依赖途径改善肝脂肪变性,从而提高法尼醇 X 受体的表达。
Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan;385(1):51-6. doi: 10.1007/s00210-011-0691-1. Epub 2011 Sep 25.
4
Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence.胍丁胺与咪唑啉受体:它们在阿片类镇痛、耐受性及依赖性中的作用。
Cell Mol Neurobiol. 2008 Aug;28(5):629-41. doi: 10.1007/s10571-007-9164-y. Epub 2007 Jul 25.
5
Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons.突触前I1-咪唑啉受体减少纹状体中型多棘神经元中的γ-氨基丁酸能突触传递。
J Neurosci. 2006 Feb 8;26(6):1795-802. doi: 10.1523/JNEUROSCI.4642-05.2006.
6
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands.体外通过咪唑啉受体配体对氨基脲敏感胺氧化酶活性的变构调节
Br J Pharmacol. 2004 Oct;143(4):495-507. doi: 10.1038/sj.bjp.0705986. Epub 2004 Sep 27.
7
Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?受体和酶上的咪唑啉结合位点:新型抗抑郁药物的新兴靶点?
J Psychiatry Neurosci. 2003 Nov;28(6):409-14.